95
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Asymptomatic Hyperuricemia Associates with Cardiometabolic Risk Indicators in Overweight/Obese but Not in Lean Adolescents

ORCID Icon, ORCID Icon & ORCID Icon
Pages 3977-3992 | Published online: 27 Oct 2020

References

  • Ogura T, Matsuura K, Matsumoto Y, et al. Recent trends of hyperuricemia and obesity in Japanese male adolescents, 1991 through 2002. Metabolism. 2004;53(4):448–453. doi:10.1016/j.metabol.2003.11.017
  • Bonora E, Targher G, Zenere MB, et al. Relationship of uric acid concentration to cardiovascular risk factors in young men. Role of obesity and central fat distribution. The verona young men atherosclerosis risk factors study. Int J Obes Relat Metab Disord. 1996;20(11):975–980.
  • Ford ES, Li C, Cook S, Choi HK. Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents. Circulation. 2007;115(19):2526–2532. doi:10.1161/CIRCULATIONAHA.106.657627
  • Goncalves JP, Ramos E, Severo M, et al. Serum uric acid and cardiovascular risk among Portuguese adolescents. J Adolesc Health. 2015;56(4):376–381. doi:10.1016/j.jadohealth.2014.11.010
  • Wasilewska A, Tenderenda E, Taranta-Janusz K, Tobolczyk J, Stypulkowska J. Markers of systemic inflammation in children with hyperuricemia. Acta Paediatr. 2012;101(5):497–500. doi:10.1111/j.1651-2227.2011.02582.x
  • Lee AM, Gurka MJ, DeBoer MD. Correlation of metabolic syndrome severity with cardiovascular health markers in adolescents. Metabolism. 2017;69:87–95. doi:10.1016/j.metabol.2017.01.008
  • Sun HL, Pei D, Lue KH, Chen YL. Uric acid levels can predict metabolic syndrome and hypertension in adolescents: a 10-year longitudinal study. PLoS One. 2015;10(11):e0143786. doi:10.1371/journal.pone.0143786
  • Kumar R, Khalsa DD, Carmody JB. Serum uric acid and hyperuricemia in U.S. adolescents: 40-year trends. Clin Exp Rheumatol. 2016;34(1 Suppl 95):S2223.
  • Tang L, Kubota M, Nagai A, Mamemoto K, Tokuda M. Hyperuricemia in obese children and adolescents: the relationship with metabolic syndrome. Pediatr Rep. 2010;2(1):e12.
  • Luciano R, Shashaj B, Spreghini M, et al. Percentiles of serum uric acid and cardiometabolic abnormalities in obese Italian children and adolescents. Ital J Pediatr. 2017;43(1):3. doi:10.1186/s13052-016-0321-0
  • Ozalp Kizilay D, Sen S. Associations between serum uric acid concentrations and cardiometabolic risk and renal injury in obese and overweight children. J Clin Res Pediatr Endocrinol. 2019;11(3):262–269. doi:10.4274/jcrpe.galenos.2018.2019.0241
  • Ricotti R, Genoni G, Giglione E, et al. High-normal estimated glomerular filtration rate and hyperuricemia positively correlate with metabolic impairment in pediatric obese patients. PLoS One. 2018;13(3):e0193755. doi:10.1371/journal.pone.0193755
  • Santucci MP, Muzzio ML, Peredo MS, et al. Different alterations of glomerular filtration rate and their association with uric acid in children and adolescents with type 1 diabetes or with overweight/obesity. Pediatr Diabetes. 2020;21(4):657–663. doi:10.1111/pedi.13008
  • Rochlani Y, Pothineni NV, Mehta JL. Metabolic syndrome: does it differ between women and men? Cardiovasc Drugs Ther. 2015;29(4):329–338.
  • Ostrihonova T, Rimarova K, Beresova J, Kontrosova S, Dorko E, Diabelkova J. Prevalence and trends of metabolic syndrome in slovakia during the period of 2003-2012. Cent Eur J Public Health. 2017;25(4):313–320. doi:10.21101/cejph.a4968
  • Gurecka R, Koborova I, Sebek J, Sebekova K. Presence of cardiometabolic risk factors is not associated with microalbuminuria in 14-to-20-years old slovak adolescents: a cross-sectional, population study. PLoS One. 2015;10(6):e0129311. doi:10.1371/journal.pone.0129311
  • Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: IR and beta-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia. 1985;28(7):412–419. doi:10.1007/BF00280883
  • Dobiasova M, Frohlich J. The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FER(HDL)). Clin Biochem. 2001;34(7):583–588. doi:10.1016/S0009-9120(01)00263-6
  • Pottel H, Hoste L, Dubourg L, et al. An estimated glomerular filtration rate equation for the full age spectrum. Nephrol Dial Transplant. 2016;31(5):798–806. doi:10.1093/ndt/gfv454
  • Soldatovic I, Vukovic R, Culafic D, Gajic M, Dimitrijevic-Sreckovic V. siMS Score: simple Method for Quantifying Metabolic Syndrome. PLoS One. 2016;11(1):e0146143. doi:10.1371/journal.pone.0146143
  • Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ. 2000;320(7244):1240–1243. doi:10.1136/bmj.320.7244.1240
  • Sebekova K, Stefikova K, Polakovicova D, Spustova V, Dzurik R. Does magnesium dysbalance participate in the development of insulin resistance in early stages of renal disease? Physiol Res. 2002;51(6):605–612.
  • Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation. 2003;107(3):363–369. doi:10.1161/01.CIR.0000053730.47739.3C
  • Hertelyova Z, Vaskova J, Vasko L. Waist circumference-to-height ratio detected in a convenient sample of young slovak people with increased cardio-metabolic risk. Cent Eur J Public Health. 2016;24(2):95–102. doi:10.21101/cejph.a4007
  • Kubota M. Hyperuricemia in children and adolescents: present knowledge and future directions. J Nutr Metab. 2019;2019:3480718. doi:10.1155/2019/3480718
  • Krzystek-Korpacka M, Patryn E, Kustrzeba-Wojcicka I, Chrzanowska J, Gamian A, Noczynska A. Gender-specific association of serum uric acid with metabolic syndrome and its components in juvenile obesity. Clin Chem Lab Med. 2011;49(1):129–136. doi:10.1515/CCLM.2011.011
  • Mele C, Tagliaferri MA, Saraceno G, et al. Serum uric acid potentially links metabolic health to measures of fuel use in lean and obese individuals. Nutr Metab Cardiovasc Dis. 2018;28(10):1029–1035. doi:10.1016/j.numecd.2018.06.010
  • Lima WG, Martins-Santos ME, Chaves VE. Uric acid as a modulator of glucose and lipid metabolism. Biochimie. 2015;116:17–23. doi:10.1016/j.biochi.2015.06.025
  • Wan X, Xu C, Lin Y, et al. Uric acid regulates hepatic steatosis and insulin resistance through the NLRP3 inflammasome-dependent mechanism. J Hepatol. 2016;64(4):925–932. doi:10.1016/j.jhep.2015.11.022
  • Volpe A, Ye C, Hanley AJ, Connelly PW, Zinman B, Retnakaran R. Changes over time in uric acid in relation to changes in insulin sensitivity, beta-cell function, and glycemia. J Clin Endocrinol Metab. 2020;105(3):e651e659. doi:10.1210/clinem/dgz199
  • Shani M, Vinker S, Dinour D, et al. High normal uric acid levels are associated with an increased risk of diabetes in lean, normoglycemic healthy women. J Clin Endocrinol Metab. 2016;101(10):3772–3778. doi:10.1210/jc.2016-2107
  • Johnson RJ, Nakagawa T, Sanchez-Lozada LG, et al. Sugar, uric acid, and the etiology of diabetes and obesity. Diabetes. 2013;62(10):3307–3315. doi:10.2337/db12-1814
  • Lin YK, Lin YP, Lee JT, et al. Sex-specific association of hyperuricemia with cardiometabolic abnormalities in a military cohort: the CHIEF study. Medicine. 2020;99(12):e19535. doi:10.1097/MD.0000000000019535
  • Kuwabara M, Borghi C, Cicero AFG, et al. Elevated serum uric acid increases risks for developing high LDL cholesterol and hypertriglyceridemia: A five-year cohort study in Japan. Int J Cardiol. 2018;261:183–188. doi:10.1016/j.ijcard.2018.03.045
  • Wang Y, Hu JW, Lv YB, et al. The role of uric acid in hypertension of adolescents, prehypertension and salt sensitivity of blood pressure. Med Sci Monit. 2017;23:790–795. doi:10.12659/MSM.899563
  • Cortese F, Giordano P, Scicchitano P, et al. Uric acid: from a biological advantage to a potential danger. A focus on cardiovascular effects. Vascul Pharmacol. 2019;120:106565. doi:10.1016/j.vph.2019.106565
  • Tian S, Liu Y, Xu Y, Feng A. Does obesity modify the epidemiological association between hyperuricemia and the prevalence of hypertension among Northern Chinese community-dwelling people? A Chinese population-based study. BMJ Open. 2019;9(11):e031803. doi:10.1136/bmjopen-2019-031803
  • Leiba A, Vinker S, Dinour D, Holtzman EJ, Shani M. Uric acid levels within the normal range predict increased risk of hypertension: a cohort study. J Am Soc Hypertens. 2015;9(8):600–609. doi:10.1016/j.jash.2015.05.010
  • Hsia SH, Chou IJ, Kuo CF, et al. Survival impact of serum uric acid levels in children and adolescents. Rheumatol Int. 2013;33(11):2797–2802. doi:10.1007/s00296-013-2808-y
  • Lu J, Sun W, Cui L, et al. A cross-sectional study on uric acid levels among Chinese adolescents. Pediatr Nephrol. 2020;35(3):441–446. doi:10.1007/s00467-019-04357-w
  • Okada R, Yasuda Y, Tsushita K, Wakai K, Hamajima N, Matsuo S. Glomerular hyperfiltration in prediabetes and prehypertension. Nephrol Dial Transplant. 2012;27(5):1821–1825. doi:10.1093/ndt/gfr651
  • Li Y, Zhong X, Cheng G, et al. Hs-CRP and all-cause, cardiovascular, and cancer mortality risk: A meta-analysis. Atherosclerosis. 2017;259:75–82. doi:10.1016/j.atherosclerosis.2017.02.003
  • Ruggiero C, Cherubini A, Miller E 3rd, et al. Usefulness of uric acid to predict changes in C-reactive protein and interleukin-6 in 3-year period in Italians aged 21 to 98 years. Am J Cardiol. 2007;100(1):115–121. doi:10.1016/j.amjcard.2007.02.065
  • Bo S, Gentile L, Ciccone G, et al. The metabolic syndrome and high C-reactive protein: prevalence and differences by sex in a southern-European population-based cohort. Diabetes Metab Res Rev. 2005;21(6):515–524. doi:10.1002/dmrr.561
  • Redon J, Cifkova R, Laurent S, et al. The metabolic syndrome in hypertension: european society of hypertension position statement. J Hypertens. 2008;26(10):1891–1900. doi:10.1097/HJH.0b013e328302ca38
  • Karuparthi PR, Yerram P, Lastra G, Hayden MR, Sowers JR. Understanding essential hypertension from the perspective of the cardiometabolic syndrome. J Am Soc Hypertens. 2007;1(2):120–134. doi:10.1016/j.jash.2007.01.006
  • Manrique C, Lastra G, Whaley-Connell A, Sowers JR. Hypertension and the cardiometabolic syndrome. J Clin Hypertens. 2005;7(8):471–476. doi:10.1111/j.1524-6175.2005.04617.x
  • Zhao G, Huang L, Song M, Song Y. Baseline serum uric acid level as a predictor of cardiovascular disease related mortality and all-cause mortality: a meta-analysis of prospective studies. Atherosclerosis. 2013;231(1):61–68. doi:10.1016/j.atherosclerosis.2013.08.023
  • Norvik JV, Storhaug HM, Ytrehus K, et al. Overweight modifies the longitudinal association between uric acid and some components of the metabolic syndrome: the Tromsø Study. BMC Cardiovasc Disord. 2016;16:85. doi:10.1186/s12872-016-0265-8